Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
#1223 ALLN-346 a urate degrading enzyme in a pig model of gout
L06 Emapalumab for…
Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush
Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Study of ANA+ people without lupus or CTD shows that fatigue does not increase odds of having lupus or CTD.…
A Spanish prospective cohort of active, uncontrolled gout patients were followed and showed that failure to reach a target serum uric acid (sUA) level of 6 mg/dl (0.36 mmol/L) or less was associated…
A cohort study of 97 patients with psoriatic arthritis (PsA) examined the prescribing practices in PsA, and found biologics are commonly initiated as the primary mode of therapy in outpatients with…
